Intravenous Acetaminophen After Cardiac Surgery - Definitive Study
NCT ID: NCT06613178
Last Updated: 2024-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
1100 participants
INTERVENTIONAL
2024-07-02
2027-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
IV Acetaminophen After Cardiac Surgery - PILOT
NCT05246644
Pain Control After Cardiac Surgery Using Intravenous Acetaminophen
NCT01822821
IV Acetaminophen as an Adjunct Analgesic in Cardiac Surgery
NCT01544062
Assessing the Efficacy of Intravenous Acetaminophen Versus the Oral Formulation for Perioperative Pain Treatment
NCT02216682
Polypharmacy and Outcomes After Elective Noncardiac Surgery
NCT03133182
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We also will assess use of NSAID, specifically ketorolac, and any NSAID associated events.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral Placebo
Subject receives active intravenous acetaminophen and oral placebo acetaminophen
acetaminophen
Patient receive IV acetaminophen (and oral placebo) or placebo IV acetaminophen and oral acetaminophen. All drugs are blinded
Oral Acetaminophen
Subject receives placebo IV fluid (saline) and active oral acetaminophen
acetaminophen
Patient receive IV acetaminophen (and oral placebo) or placebo IV acetaminophen and oral acetaminophen. All drugs are blinded
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acetaminophen
Patient receive IV acetaminophen (and oral placebo) or placebo IV acetaminophen and oral acetaminophen. All drugs are blinded
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* elective cardiac surgery
* stable pre-operative
* aorto-coronary bypass with or without 1 valve replacement.
Exclusion Criteria
\-
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laval University
OTHER
University of British Columbia
OTHER
St. Boniface Hospital
OTHER
University of Ottawa
OTHER
Trillium Health Centre
OTHER
Université de Montréal
OTHER
Sunnybrook Health Sciences Centre
OTHER
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
magder sheldon
Principle Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of British Columbia
Vancouver, British Columbia, Canada
University of Manitoba
Winnipeg, Manitoba, Canada
Trillium Health Centre
Mississagua, Ontario, Canada
University of Ottawa
Ottawa, Ontario, Canada
Sunnybroook Health Centre
Toronto, Ontario, Canada
McGill Universtiy Health Centre
Montreal, Quebec, Canada
Universite Montreal
Montreal, Quebec, Canada
University of Laval
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rayhaneh Rahgoshai, BA
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MUHC-ACETAMINOPHEN FULL STUDY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.